1-5 of 5
Jay Y. Spiegel
Close
Sort by
Journal Articles

Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy

Rick Y Lin, Anthony D Anderson, Yoichiro Natori, Mohammed Raja, Michele I Morris, Antonio M Jimenez Jimenez, Amer Beitinjaneh, Trent Wang, Mark Goodman, Lazaros J. Lekakis, Jay Y Spiegel, Noa G Holtzman, Denise L. Pereira, Cara L Benjamin, Akina Natori, Krishna V Komanduri, Jose F Camargo
Journal: Blood Advances
Blood Adv bloodadvances.2024012922.
https://doi.org/10.1182/bloodadvances.2024012922
Published: 2024
Includes: Supplemental data
Journal Articles

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Clinical Trials & Observations
Michael D. Jain, Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Alison R. Sehgal, Andre Goy, Brian T. Hill, Charalambos Andreadis, Javier Munoz, Julio C Chavez, N. Nora Bennani, Aaron P. Rapoport, Julie M. Vose, David Miklos, Sattva S. Neelapu, Frederick L. Locke, Armin Ghobadi
Journal: Blood Advances
Blood Adv (2024) 8 (4): 1042–1050.
https://doi.org/10.1182/bloodadvances.2023011489
Published: 2024
Includes: Supplemental data
Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, Sally Arai, Matthew J. Frank, Laura J. Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T. Vempaty, David B. Miklos
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3147–3151.
https://doi.org/10.1182/bloodadvances.2021004234
Published: 2021
Includes: Supplemental data
Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Clinical Trials & Observations
John H. Baird, David J. Epstein, John S. Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, Janice (Wes) Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen-Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (1): 143–155.
https://doi.org/10.1182/bloodadvances.2020002732
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

Clinical Trials & Observations
Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1729–1738.
https://doi.org/10.1182/bloodadvances.2017009530
Published: 2017
Includes: Supplemental data